XXX - Bifidobacterium animalis lactis BB-12 + Lactobacillus acidophilus La-5 & Type 2 diabetes (T2D)

Study overview

It is a randomized double-blind controlled clinical trial studying daily 300 g of probiotic yogurt containing Bifidobacterium animalis lactis BB-12 + Lactobacillus acidophilus La5 or conventional yogurt (control) for six weeks in 60 enrolled patients with Type 2 diabetes (T2D)(1) (body mass index of less than 35 kg/m^2 and LDL-C greater or equal to 2.6 mmol/L (100 mg/dL) (1).

Outcome measures

Fasting blood samples, anthropometric measurements and 3-d, 24-h dietary recalls (1).

Results

• Total Cholesterol: Probiotic yogurt led to a 4.54% reduction.


• LDL-C: There was a 7.45% reduction in LDL-C levels.


• Triglycerides and HDL-C: No significant c…